Detalles de la búsqueda
1.
Influenza Hospitalization Burden by Subtype, Age, Comorbidity, and Vaccination Status: 2012-2013 to 2018-2019 Seasons, Quebec, Canada.
Clin Infect Dis
; 78(3): 765-774, 2024 03 20.
Artículo
en Inglés
| MEDLINE | ID: mdl-37819010
2.
Timing and Predictors of Loss of Infectivity Among Healthcare Workers With Mild Primary and Recurrent COVID-19: A Prospective Observational Cohort Study.
Clin Infect Dis
; 78(3): 613-624, 2024 03 20.
Artículo
en Inglés
| MEDLINE | ID: mdl-37675577
3.
Single-dose Effectiveness of Mpox Vaccine in Quebec, Canada: Test-negative Design With and Without Adjustment for Self-reported Exposure Risk.
Clin Infect Dis
; 78(2): 461-469, 2024 02 17.
Artículo
en Inglés
| MEDLINE | ID: mdl-37769158
4.
Monkeypox in Montréal: Epidemiology, Phylogenomics, and Public Health Response to a Large North American Outbreak.
Ann Intern Med
; 176(1): 67-76, 2023 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-36508736
5.
2023/24 mid-season influenza and Omicron XBB.1.5 vaccine effectiveness estimates from the Canadian Sentinel Practitioner Surveillance Network (SPSN).
Euro Surveill
; 29(7)2024 Feb.
Artículo
en Inglés
| MEDLINE | ID: mdl-38362622
6.
Vaccine effectiveness estimates from an early-season influenza A(H3N2) epidemic, including unique genetic diversity with reassortment, Canada, 2022/23.
Euro Surveill
; 28(5)2023 02.
Artículo
en Inglés
| MEDLINE | ID: mdl-36729117
7.
Influenza Vaccine Effectiveness by A(H3N2) Phylogenetic Subcluster and Prior Vaccination History: 2016-2017 and 2017-2018 Epidemics in Canada.
J Infect Dis
; 225(8): 1387-1398, 2022 04 19.
Artículo
en Inglés
| MEDLINE | ID: mdl-32215564
8.
Impact of temperature on the affinity of SARS-CoV-2 Spike glycoprotein for host ACE2.
J Biol Chem
; 297(4): 101151, 2021 10.
Artículo
en Inglés
| MEDLINE | ID: mdl-34478710
9.
Natural spring water gargle samples as an alternative to nasopharyngeal swabs for SARS-CoV-2 detection using a laboratory-developed test.
J Med Virol
; 94(3): 985-993, 2022 03.
Artículo
en Inglés
| MEDLINE | ID: mdl-34672374
10.
Influenza vaccine effectiveness against A(H3N2) during the delayed 2021/22 epidemic in Canada.
Euro Surveill
; 27(38)2022 09.
Artículo
en Inglés
| MEDLINE | ID: mdl-36148674
11.
Relative Severity of Common Human Coronaviruses and Influenza in Patients Hospitalized With Acute Respiratory Infection: Results From 8-Year Hospital-Based Surveillance in Quebec, Canada.
J Infect Dis
; 223(6): 1078-1087, 2021 03 29.
Artículo
en Inglés
| MEDLINE | ID: mdl-32761209
12.
Influenza Vaccine Does Not Increase the Risk of Coronavirus or Other Noninfluenza Respiratory Viruses: Retrospective Analysis From Canada, 2010-2011 to 2016-2017.
Clin Infect Dis
; 71(16): 2285-2288, 2020 11 19.
Artículo
en Inglés
| MEDLINE | ID: mdl-32442261
13.
Interim estimates of 2019/20 vaccine effectiveness during early-season co-circulation of influenza A and B viruses, Canada, February 2020.
Euro Surveill
; 25(7)2020 02.
Artículo
en Inglés
| MEDLINE | ID: mdl-32098644
14.
Vaccine Effectiveness Against Lineage-matched and -mismatched Influenza B Viruses Across 8 Seasons in Canada, 2010-2011 to 2017-2018.
Clin Infect Dis
; 68(10): 1754-1757, 2019 05 02.
Artículo
en Inglés
| MEDLINE | ID: mdl-30312364
15.
Respiratory syncytial virus contributes to more severe respiratory morbidity than influenza in children < 2 years during seasonal influenza peaks.
Infection
; 47(4): 595-601, 2019 Aug.
Artículo
en Inglés
| MEDLINE | ID: mdl-30798473
16.
Children under 10 years of age were more affected by the 2018/19 influenza A(H1N1)pdm09 epidemic in Canada: possible cohort effect following the 2009 influenza pandemic.
Euro Surveill
; 24(15)2019 Apr.
Artículo
en Inglés
| MEDLINE | ID: mdl-30994107
17.
Paradoxical clade- and age-specific vaccine effectiveness during the 2018/19 influenza A(H3N2) epidemic in Canada: potential imprint-regulated effect of vaccine (I-REV).
Euro Surveill
; 24(46)2019 Nov.
Artículo
en Inglés
| MEDLINE | ID: mdl-31771709
18.
Interim estimates of 2018/19 vaccine effectiveness against influenza A(H1N1)pdm09, Canada, January 2019.
Euro Surveill
; 24(4)2019 Jan.
Artículo
en Inglés
| MEDLINE | ID: mdl-30696523
19.
Early season co-circulation of influenza A(H3N2) and B(Yamagata): interim estimates of 2017/18 vaccine effectiveness, Canada, January 2018.
Euro Surveill
; 23(5)2018 02.
Artículo
en Inglés
| MEDLINE | ID: mdl-29409570
20.
Beyond Antigenic Match: Possible Agent-Host and Immuno-epidemiological Influences on Influenza Vaccine Effectiveness During the 2015-2016 Season in Canada.
J Infect Dis
; 216(12): 1487-1500, 2017 12 19.
Artículo
en Inglés
| MEDLINE | ID: mdl-29029166